DMB-3113

DMB-3113 · Meiji Seika Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMB-3113, covering 2017-08-22 to 2017-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects [Phase 1]

See pricing